<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Clean-Musk-Fragrance-Formulation on Bioecon</title><link>https://en.bioecon.ru/technologies/clean-musk-fragrance-formulation/</link><description>Recent content in Clean-Musk-Fragrance-Formulation on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 21 Jul 2026 17:05:46 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/clean-musk-fragrance-formulation/index.xml" rel="self" type="application/rss+xml"/><item><title>Biosynthetic musk &amp; aromas</title><link>https://en.bioecon.ru/technology/biosynthetic-musk-aromas/</link><pubDate>Tue, 21 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/biosynthetic-musk-aromas/</guid><description>The confirmed 2026 commercial market for non-animal musk is dominated by established macrocyclic ketone/lactone brands — Givaudan&amp;rsquo;s Velvione (a 16-membered macrocyclic musk ketone) and DSM-Firmenich&amp;rsquo;s Exaltolide — plus IFF&amp;rsquo;s newly launched Orionide Oliffac clean-musk line (unveiled at SIMPPAR 2026) and, in China, Beijing Lianxin Pharmaceutical&amp;rsquo;s state-designated Class-1 artificial-musk substitute for traditional-medicine use (founded 1999, National S&amp;amp;T Progress Award), while the engineered-yeast fermentation route described in early research (omega-oxidation, lipase-catalyzed macrocyclization) remains at the patent-application stage with no confirmed commercial fermentation-musk originator.</description></item></channel></rss>